VERSATILITY BY DESIGN

Treatment with iovera° can be performed by an orthopedic surgeon, nurse practitioner, or physician assistant in a physician’s office, ambulatory surgery center (ASC), or hospital-based outpatient department (HOPD). It is used in operative and non-operative sports medicine, anesthesia, and in pain management protocols. iovera° is approved for any peripheral sensory nerve and is able to treat a range of applications outside of the knee.

 

Dr Varacallo video

Handpiece components

handpiece

Handpiece

charging-dock

Charging Dock &
Power Cord

  • An LCD display that indicates cycle stages, cartridge use, battery power, and more
  • Balanced weight distribution to reduce hand fatigue

Disposable components ordered separately

N<sub>2</sub>O Cartridge

N2O Cartridge

Smart Tip 2309

Smart Tip 2309

Smart Tip 2190

Smart Tip 2190 & Smart Tip 2190 With Nerve Stim

SMART TIP OPTIONS TO FIT YOUR TREATMENT GOALS

Two different Smart Tips give health care providers the flexibility to decide how to perform the treatment.

Use ultrasound guidance or map out anatomical landmarks to perform the procedure across identified treatment lines.

Smart Tip 2309

3-needle
  • Three 27-gauge needles, 8.5 mm long
  • Ultrasound is not needed; however, it can be used before treatment for nerve identification
  • Ideally suited for superficial nerves, including the AFCN and ISN

Smart Tip 2190 & Smart Tip 2190 With Nerve Stim

iovera g vertical
  • Single 20-gauge needle, 90 mm long
  • Ultrasound is required for nerve identification and during treatment
  • Ideally suited for deeper nerves: can also treat superficial nerves

AFCN=anterior femoral cutaneous nerve; ISN=infrapatellar branch of the saphenous nerve.

ice left

See iovera° in action

schedule a demo

See cryoneurolysis with iovera°

HOW iovera° WORKS

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue.

When stimulation compatible components are used, the iovera° system can also facilitate target nerve location by conducting electrical nerve stimulation from a compatible 3rd party nerve stimulator.

Important Safety Information

Contraindications

The iovera° system is contraindicated for use in patients with the following:

  • Cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud’s disease, and open and/or infected wounds at or near the treatment site

Potential Complications

As with any surgical treatment that uses needle-based therapy and local anesthesia, there is a potential for site-specific reactions, including, but not limited to:

  • Ecchymosis, edema, erythema, local pain and/or tenderness, and localized dysesthesia

Proper use of the device as described in the User Guide can help reduce or prevent the following complications:

  • At the treatment site(s): injury to the skin related to application of cold or heat, hyper- or hypopigmentation, and skin dimpling
  • Outside the treatment site(s): loss of motor function
More +

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain.

Important Safety Information